Swiss National Bank’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Hold |
172,600
| – | – | ﹤0.01% | 1583 |
|
|
2025
Q1 | $3.37M | Buy |
172,600
+34,800
| +25% | +$680K | ﹤0.01% | 1481 |
|
|
2024
Q4 | $3.42M | Buy |
137,800
+1,100
| +0.8% | +$27.3K | ﹤0.01% | 1538 |
|
|
2024
Q3 | $3.35M | Hold |
136,700
| – | – | ﹤0.01% | 1564 |
|
|
2024
Q2 | $3.2M | Hold |
136,700
| – | – | ﹤0.01% | 1550 |
|
|
2024
Q1 | $4.52M | Buy |
136,700
+4,100
| +3% | +$135K | ﹤0.01% | 1360 |
|
|
2023
Q4 | $3.61M | Sell |
132,600
-9,800
| -7% | -$267K | ﹤0.01% | 1489 |
|
|
2023
Q3 | $3.42M | Buy |
142,400
+16,300
| +13% | +$392K | ﹤0.01% | 1514 |
|
|
2023
Q2 | $4.03M | Buy |
126,100
+4,400
| +4% | +$140K | ﹤0.01% | 1439 |
|
|
2023
Q1 | $3.73M | Sell |
121,700
-14,200
| -10% | -$435K | ﹤0.01% | 1440 |
|
|
2022
Q4 | $5.32M | Buy |
135,900
+2,600
| +2% | +$102K | ﹤0.01% | 1278 |
|
|
2022
Q3 | $6.35M | Buy |
133,300
+4,800
| +4% | +$229K | ﹤0.01% | 1136 |
|
|
2022
Q2 | $4.97M | Buy |
128,500
+47,900
| +59% | +$1.85M | ﹤0.01% | 1322 |
|
|
2022
Q1 | $4.62M | Buy |
80,600
+7,500
| +10% | +$430K | ﹤0.01% | 1484 |
|
|
2021
Q4 | $5.83M | Buy |
73,100
+3,900
| +6% | +$311K | ﹤0.01% | 1362 |
|
|
2021
Q3 | $6.02M | Buy |
69,200
+1,700
| +3% | +$148K | ﹤0.01% | 1335 |
|
|
2021
Q2 | $8.69M | Buy |
67,500
+27,800
| +70% | +$3.58M | 0.01% | 1101 |
|
|
2021
Q1 | $3.18M | Buy |
39,700
+1,400
| +4% | +$112K | ﹤0.01% | 1725 |
|
|
2020
Q4 | $3.13M | Buy |
38,300
+9,700
| +34% | +$792K | ﹤0.01% | 1655 |
|
|
2020
Q3 | $704K | Hold |
28,600
| – | – | ﹤0.01% | 2267 |
|
|
2020
Q2 | $801K | Buy |
+28,600
| New | +$801K | ﹤0.01% | 2225 |
|